European Parliament Urges Increased Role For Generics And Biosimilars

Industry Welcomes Call For A ‘Greater Market Presence’ For Off-Patent Drugs

European parliament chamber
The European Parliament has adopted a report urging a greater presence for generics and biosimilars • Source: Alamy

More from Policy & Regulation

More from Generics Bulletin